Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus. Authors' reply.

Pan CQ, Zhang H.

Aliment Pharmacol Ther. 2019 Aug;50(4):477-478. doi: 10.1111/apt.15382. No abstract available.

PMID:
31359484
2.

Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients.

Podlaha O, Gane E, Brunetto M, Fung S, Chuang WL, Pan CQ, Jiang Z, Liu Y, Bhardwaj N, Mukherjee P, Flaherty J, Gaggar A, Subramanian M, Izumi N, Shalimar, Lim YS, Marcellin P, Buti M, Chan HLY, Agarwal K.

Sci Rep. 2019 Jul 19;9(1):10529. doi: 10.1038/s41598-019-46609-7.

3.

Engineering an anti-CD52 antibody for enhanced deamidation stability.

Qiu H, Wei R, Jaworski J, Boudanova E, Hughes H, VanPatten S, Lund A, Day J, Zhou Y, McSherry T, Pan CQ, Sendak R.

MAbs. 2019 Jul 18:1-10. doi: 10.1080/19420862.2019.1631117. [Epub ahead of print]

PMID:
31199181
4.

The risk of bloodstream infection associated with totally implantable venous access ports in cancer patient: a systematic review and meta-analysis.

Jiang M, Li CL, Pan CQ, Yu L.

Support Care Cancer. 2019 May 2. doi: 10.1007/s00520-019-04809-x. [Epub ahead of print]

PMID:
31044308
5.

Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus. Author's reply.

Pan CQ.

Aliment Pharmacol Ther. 2019 Mar;49(6):824-825. doi: 10.1111/apt.15167. No abstract available.

PMID:
30811642
6.

Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.

Birrane G, Beigneux AP, Dwyer B, Strack-Logue B, Kristensen KK, Francone OL, Fong LG, Mertens HDT, Pan CQ, Ploug M, Young SG, Meiyappan M.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1723-1732. doi: 10.1073/pnas.1817984116. Epub 2018 Dec 17.

7.

Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.

Wang M, Bian Q, Zhu Y, Pang Q, Chang L, Li R, Tiongson BC, Zhang H, Pan CQ.

Aliment Pharmacol Ther. 2019 Jan;49(2):211-217. doi: 10.1111/apt.15064. Epub 2018 Dec 2.

PMID:
30506691
8.

Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes.

Younossi ZM, Stepanova M, Younossi I, Pan CQ, Janssen HLA, Papatheodoridis G, Nader F.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1641-1642.e1. doi: 10.1016/j.cgh.2018.09.041. Epub 2018 Sep 27.

PMID:
30268565
9.

Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.

Xie W, Wang Q, Gao Y, Pan CQ.

BMC Gastroenterol. 2018 Sep 29;18(1):142. doi: 10.1186/s12876-018-0869-9.

10.

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.

Lee HM, Ahn J, Kim WR, Lim JK, Nguyen M, Pan CQ, Kim D, Mannalithara A, Te H, Trinh H, Chu D, Tran T, Woog J, Lok AS.

Dig Dis Sci. 2019 Feb;64(2):358-366. doi: 10.1007/s10620-018-5281-3. Epub 2018 Sep 20.

PMID:
30238203
11.

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection.

Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, Shalimar, Buti M, Cox S, Parhy B, Zhou E, Martin R, Chang S, Lin L, Flaherty JF, Kitrinos KM, Gaggar A, Izumi N, Lim YS.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct.

12.

[Evaluation on efficacy of corticotomy-facilitated treatment in skeletal class Ⅱ patients].

Cheng L, Zhao CY, Li M, Pan CQ, Yan B, Wang L.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2017 Jul 9;52(7):404-409. doi: 10.3760/cma.j.issn.1002-0098.2017.07.003. Chinese.

PMID:
29972903
13.

Real-World Study on Sofosbuvir-based Therapies in Asian Americans With Chronic Hepatitis C.

Pan CQ, Tiongson BC, Hu KQ, Han SB, Tong M, Chu D, Park J, Lee TP, Bhamidimarri KR, Ma X, Xiao PY, Mohanty SR, Wang D.

J Clin Gastroenterol. 2019 Feb;53(2):147-154. doi: 10.1097/MCG.0000000000001078.

PMID:
29912759
14.

Editorial: an expert consensus for the management of chronic hepatitis B in Asian Americans-Authors' reply.

Tong MJ, Pan CQ.

Aliment Pharmacol Ther. 2018 Jun;47(11):1542-1543. doi: 10.1111/apt.14662. No abstract available.

PMID:
29878433
15.

Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy.

Cao WH, Li MH, Pan CQ, Lu Y, Zhang L, Ran CP, Wu SL, Hua WH, Liu SA, Shen G, Chang M, Liu RY, Hao HX, Hu LP, Xie Y.

J Interferon Cytokine Res. 2018 May;38(5):197-205. doi: 10.1089/jir.2018.0014.

PMID:
29791282
16.

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.

Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators.

J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17.

PMID:
29756595
17.

The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B.

Yi W, Pan CQ, Li MH, Wan G, Lv YW, Liu M, Hu YH, Zhang ZY, Xie Y.

Am J Gastroenterol. 2018 May;113(5):686-693. doi: 10.1038/s41395-018-0010-2. Epub 2018 Feb 27.

PMID:
29487412
18.

An expert consensus for the management of chronic hepatitis B in Asian Americans.

Tong MJ, Pan CQ, Han SB, Lu DS, Raman S, Hu KQ, Lim JK, Hann HW, Min AD.

Aliment Pharmacol Ther. 2018 Apr;47(8):1181-1200. doi: 10.1111/apt.14577. Epub 2018 Feb 26.

19.

[A clinical study of antiviral therapy for patients with compensated hepatitis C cirrhosis].

Xie ZW, Li JP, Guan YJ, Zhang XY, Guo FX, Chen BB, Pan CQ.

Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):827-833. doi: 10.3760/cma.j.issn.1007-3418.2017.11.006. Chinese.

PMID:
29325276
20.

Prevalence of NS5B resistance-associated variants in treatment-naïve Asian patients with chronic hepatitis C.

Yang S, Xing H, Feng S, Ju W, Liu S, Wang X, Ou W, Cheng J, Pan CQ.

Arch Virol. 2018 Feb;163(2):467-473. doi: 10.1007/s00705-017-3640-6. Epub 2017 Nov 15.

PMID:
29143142
21.

Step-By-Step Traction of a Palatally Impacted Canine.

Pan CQ, Gu Y, Ma JQ, Zhao CY.

J Clin Orthod. 2017 Jun;51(6):335-345. No abstract available.

PMID:
29059061
22.

Viral factors for HBV mother-to-child transmission.

Park JS, Pan CQ.

Hepatol Int. 2017 Nov;11(6):476-480. doi: 10.1007/s12072-017-9825-y. Epub 2017 Oct 12. Review.

PMID:
29027107
23.

Differential Depth Sensing Reduces Cancer Cell Proliferation via Rho-Rac-Regulated Invadopodia.

Chaudhuri PK, Pan CQ, Low BC, Lim CT.

ACS Nano. 2017 Jul 25;11(7):7336-7348. doi: 10.1021/acsnano.7b03452. Epub 2017 Jul 3.

PMID:
28654281
24.

Angelica Dahurica ethanolic extract improves impaired wound healing by activating angiogenesis in diabetes.

Zhang XN, Ma ZJ, Wang Y, Sun B, Guo X, Pan CQ, Chen LM.

PLoS One. 2017 May 24;12(5):e0177862. doi: 10.1371/journal.pone.0177862. eCollection 2017.

25.

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, Hui AJ, Lim YS, Mehta R, Janssen HL, Acharya SK, Flaherty JF, Massetto B, Cathcart AL, Kim K, Gaggar A, Subramanian GM, McHutchison JG, Pan CQ, Brunetto M, Izumi N, Marcellin P; GS-US-320-0108 Investigators.

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):196-206. doi: 10.1016/S2468-1253(16)30107-8. Epub 2016 Sep 22. Erratum in: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):e2.

PMID:
28404092
26.

BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis.

Jiang T, Pan CQ, Low BC.

Oncogene. 2017 Jun 1;36(22):3178-3192. doi: 10.1038/onc.2016.466. Epub 2017 Jan 16.

PMID:
28092672
27.

Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.

Pan CQ, Yi W, Liu M, Wan G, Hu YH, Zhou MF.

J Viral Hepat. 2017 Mar;24(3):246-252. doi: 10.1111/jvh.12640. Epub 2016 Dec 26.

PMID:
28025872
28.

Prevention of Peripartum Hepatitis B Transmission.

Pan CQ, Han G, Wang Y.

N Engl J Med. 2016 Oct 13;375(15):1497-1498. doi: 10.1056/NEJMc1609991. No abstract available.

PMID:
27732821
29.

Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.

Liu Q, Li XL, Liu JJ, Song XH, Jiang XY, Li W, Zhang H, Pan CQ.

J Obstet Gynaecol Res. 2016 Dec;42(12):1753-1760. doi: 10.1111/jog.13124. Epub 2016 Sep 20.

PMID:
27647778
30.

Clinical Features of Chronic Hepatitis B in Treatment-naive Asian Patients With Positive HBeAg and Coexisting Precore and/or Basal Core Promoter Mutations.

Pan CQ, Dai E, Bhamidimarri KR, Zeng Z, Yin P.

J Clin Gastroenterol. 2017 Mar;51(3):261-267. doi: 10.1097/MCG.0000000000000664.

PMID:
27552328
31.

Structural basis for exploring the allosteric inhibition of human kidney type glutaminase.

Ramachandran S, Pan CQ, Zimmermann SC, Duvall B, Tsukamoto T, Low BC, Sivaraman J.

Oncotarget. 2016 Sep 6;7(36):57943-57954. doi: 10.18632/oncotarget.10791.

32.

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.

Ahn J, Lim JK, Lee HM, Lok AS, Nguyen M, Pan CQ, Mannalithara A, Te H, Reddy KR, Trinh H, Chu D, Tran T, Lau D, Leduc TS, Min A, Trong Le L, Bae H, Van Tran S, Do S, Hann HW, Wong C, Han S, Pillai A, Park JS, Tong M, Scaglione S, Woog J, Kim WR.

Am J Gastroenterol. 2016 Sep;111(9):1297-304. doi: 10.1038/ajg.2016.257. Epub 2016 Jun 21.

PMID:
27325221
33.

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.

Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H; China Study Group for the Mother-to-Child Transmission of Hepatitis B.

N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660.

34.

Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.

Lok AS, Pan CQ, Han SH, Trinh HN, Fessel WJ, Rodell T, Massetto B, Lin L, Gaggar A, Subramanian GM, McHutchison JG, Ferrari C, Lee H, Gordon SC, Gane EJ.

J Hepatol. 2016 Sep;65(3):509-16. doi: 10.1016/j.jhep.2016.05.016. Epub 2016 May 19.

PMID:
27210427
35.

The Four-Herb Chinese Medicine Formula Tuo-Li-Xiao-Du-San Accelerates Cutaneous Wound Healing in Streptozotocin-Induced Diabetic Rats through Reducing Inflammation and Increasing Angiogenesis.

Zhang XN, Ma ZJ, Wang Y, Li YZ, Sun B, Guo X, Pan CQ, Chen LM.

J Diabetes Res. 2016;2016:5639129. doi: 10.1155/2016/5639129. Epub 2015 Dec 29.

36.

Letter: lessons from the 'real-world' entecavir therapy in chronic hepatitis B patients--authors' reply.

Ahn J, Nguyen MH, Lim JK, Lee HM, Pan CQ, Lok AS.

Aliment Pharmacol Ther. 2016 Apr;43(7):847-8. doi: 10.1111/apt.13558. No abstract available.

37.

Topography induces differential sensitivity on cancer cell proliferation via Rho-ROCK-Myosin contractility.

Chaudhuri PK, Pan CQ, Low BC, Lim CT.

Sci Rep. 2016 Jan 22;6:19672. doi: 10.1038/srep19672.

38.

[Effect of bile duct ligation and recanalization on rat hepatocyte epithelial-mesenchymal phenotype and NOX4 protein expression].

Lou AN, Pan CQ, Li Y, Yang RQ, Li X.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Oct;35(10):1457-62. Chinese.

PMID:
26547341
39.

Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study.

Ahn J, Lee HM, Lim JK, Pan CQ, Nguyen MH, Ray Kim W, Mannalithara A, Trinh H, Chu D, Tran T, Min A, Do S, Te H, Reddy KR, Lok AS.

Aliment Pharmacol Ther. 2016 Jan;43(1):134-44. doi: 10.1111/apt.13440. Epub 2015 Oct 28.

40.

BNIP-H Recruits the Cholinergic Machinery to Neurite Terminals to Promote Acetylcholine Signaling and Neuritogenesis.

Sun J, Pan CQ, Chew TW, Liang F, Burmeister M, Low BC.

Dev Cell. 2015 Sep 14;34(5):555-68. doi: 10.1016/j.devcel.2015.08.006. Epub 2015 Sep 3.

41.

Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase A.

Qiu H, Honey DM, Kingsbury JS, Park A, Boudanova E, Wei RR, Pan CQ, Edmunds T.

Protein Sci. 2015 Sep;24(9):1401-11. doi: 10.1002/pro.2719. Epub 2015 Jul 14.

42.

Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.

Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L.

World J Gastroenterol. 2015 May 14;21(18):5524-31. doi: 10.3748/wjg.v21.i18.5524.

43.

[Three-dimensional localization and assessment of maxillary palatal impacted canines with cone-beam computed tomography].

Yu JN, Gu YG, Zhao CY, Liu K, Mo SC, Li H, Pan CQ, Wang L.

Shanghai Kou Qiang Yi Xue. 2015 Feb;24(1):65-70. Chinese.

PMID:
25858386
44.

Cyclic stretching of soft substrates induces spreading and growth.

Cui Y, Hameed FM, Yang B, Lee K, Pan CQ, Park S, Sheetz M.

Nat Commun. 2015 Feb 23;6:6333. doi: 10.1038/ncomms7333.

45.

[Hybrid operation for acute left leg deep venous thrombosis secondary to left iliac vein compression syndrome: analysis of 36 cases].

Zhou ZX, Fu FY, Lin ZQ, Pan CQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Jan;35(1):131-4. Chinese.

PMID:
25613628
46.

Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.

Ravi A, Kaushik S, Ravichandran A, Pan CQ, Low BC.

J Biol Chem. 2015 Feb 13;290(7):4149-62. doi: 10.1074/jbc.M114.616839. Epub 2014 Dec 18.

47.

Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.

Lu L, Yip B, Trinh H, Pan CQ, Han SH, Wong CC, Li J, Chan S, Krishnan G, Wong CC, Nguyen MH.

J Viral Hepat. 2015 Aug;22(8):675-81. doi: 10.1111/jvh.12368. Epub 2014 Nov 24.

48.

Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.

Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X.

Hepatology. 2014 Jan 27. doi: 10.1002/hep.27034. [Epub ahead of print]

49.

Structures of a pan-specific antagonist antibody complexed to different isoforms of TGFβ reveal structural plasticity of antibody-antigen interactions.

Moulin A, Mathieu M, Lawrence C, Bigelow R, Levine M, Hamel C, Marquette JP, Le Parc J, Loux C, Ferrari P, Capdevila C, Dumas J, Dumas B, Rak A, Bird J, Qiu H, Pan CQ, Edmunds T, Wei RR.

Protein Sci. 2014 Dec;23(12):1698-707. doi: 10.1002/pro.2548. Epub 2014 Sep 26.

50.

Supplemental Content

Support Center